FLT3LG and non-small cell lung carcinoma: In this study, we explored the impact of combined MWA and Flt3L treatment on NSCLC via a syngeneic murine tumor rechallenge model, the subcutaneous injection of Lewis lung carcinoma (LLC) cells.